All Stories

  1. Development of Asymmetric Facial Depigmentation in a Patient Treated with Dasatinib with New-Onset Hypovitaminosis D: Case Report and Review of the Literature
  2. Tumour necrosis factor-α inhibition can stabilize disease in progressive vitiligo